Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
Background: Fertility preservation is an important quality of life issue for women of reproductive age undergoing gonadotoxic treatment. The possibility of administering an adjuvant long-acting gonadotropin-releasing hormone agonist (GnRHa) with the aim of reducing the number of follicles susceptibl...
Saved in:
Main Authors: | Caroline Ingold (Author), Paula Andrea Navarro (Author), Renato de Oliveira (Author), Caio Parente Barbosa (Author), Giuliano Bedoschi (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
by: I-Ting Liang, et al.
Published: (2015) -
Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
by: Nobue Kojima, et al.
Published: (2018) -
Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization
by: Yao-Yuan Hsieh, et al.
Published: (2008) -
Ovarian Hyperstimulation Syndrome
Published: (2006) -
Ovarian Hyperstimulation Syndrome
Published: (2006)